Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Stem cells in the umbilical cord.

Mark L Weiss1, Deryl L Troyer

  • 1The Midwest Institute for Comparative Stem Cell Biology and the Department of Anatomy and Physiology, Kansas State University College of Veterinary Medicine, Manhattan, KS 66506-5602, USA. weiss@vet.ksu.edu

Stem Cell Reviews
|January 24, 2007
PubMed
Summary

Umbilical cord stem cells offer a promising, ethically sound alternative to embryonic sources for regenerative medicine. These multipotent cells are readily available and suitable for therapeutic applications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Procoagulant Activity of Umbilical Cord-Derived Mesenchymal Stromal Cells' Extracellular Vesicles (MSC-EVs).

International journal of molecular sciences·2023
Same author

Maternal Plasma RNA in First Trimester Nullipara for the Prediction of Spontaneous Preterm Birth ≤ 32 Weeks: Validation Study.

Biomedicines·2023
Same author

Effect of Pre-Processing Storage Condition of Cell Culture-Conditioned Medium on Extracellular Vesicles Derived from Human Umbilical Cord-Derived Mesenchymal Stromal Cells.

International journal of molecular sciences·2022
Same author

Detection of Embryonic Trisomy 21 in the First Trimester Using Maternal Plasma Cell-Free RNA.

Diagnostics (Basel, Switzerland)·2022
Same author

Peptide nanosponges designed for rapid uptake by leukocytes and neural stem cells.

RSC advances·2022
Same author

Peptide Nanosponges Designed for the Delivery of Perillyl Alcohol to Glioma Cells.

ACS applied bio materials·2022

Area of Science:

  • Regenerative Medicine
  • Stem Cell Biology
  • Biotechnology

Background:

  • Stem cells hold significant therapeutic potential for replacing damaged tissues and delivering engineered proteins.
  • Ethical and scientific concerns currently limit the clinical application of embryonic and fetal stem cells.
  • Postnatal stem cells, particularly those derived from the umbilical cord, present a viable alternative.

Purpose of the Study:

  • To review the potential of umbilical cord-derived stem cells.
  • To compare umbilical cord stem cells with adult bone marrow-derived mesenchymal stem cells.
  • To highlight the advantages of using readily available, multipotent postnatal stem cells.

Main Methods:

  • Literature review focusing on stem cell research.

Related Experiment Videos

  • Comparative analysis of different stem cell sources (umbilical cord vs. bone marrow).
  • Discussion of the multipotent nature and therapeutic applications of umbilical cord stem cells.

    • Main Results:

    • Umbilical cord stem cells (including blood, amnion/placenta, vein, and matrix cells) are multipotent and easily accessible.
    • These cells offer an inexpensive and ethically unproblematic source for cell-based therapies.
    • Umbilical cord stem cells demonstrate potential comparable to adult bone marrow-derived mesenchymal stem cells.

    Conclusions:

    • Umbilical cord-derived stem cells represent a significant advancement in regenerative medicine.
    • Their accessibility, multipotency, and ethical profile make them a preferred source over embryonic or fetal stem cells.
    • Further research and clinical translation of umbilical cord stem cells are warranted.